Study reveals role of gamma-delta T cells in cancer immunology

A study published in Cell Press reveals the significant role of gamma-delta T cells in treatment outcomes for 33 cancer types. Researchers at Moffitt Cancer Center found that these cells' diversity and clonality impact patient survival and treatment efficacy, providing new clinical biomarkers and therapeutic targets.